Syneron raises $150m for macrocyclics, and other financings Our round-up of recent biotech venture capital financings includes nine-figure rounds for Syneron, Stipple Bio, and Sidewinder.

#Chinesestartup #SyneronBio has closed a $150 million second round, just four months after its $100 million first round, as it strives to carve out a position in the competitive #macrocyclicpeptide category.

pharmaphorum.com/news/syneron...